Business is booming.

WHO approves China’s Sinovac COVID-19 vaccine

By Nneka Nwogwugwu

The World Health Organization (WHO) has approved the emergency use of a COVID-19 jab made by Sinovac, paving the way for a second vaccine produced in China to be distributed among developing countries.

The UN health agency gave the green light to the two-shot vaccine on Tuesday as the jab “meets international standards for safety, efficacy and manufacturing”, read a statement.

WHO Director-General Tedros Adhanom Ghebreyesus welcomed the move, noting the vaccine’s easy storage requirements make it suitable for low-income countries.

“It’s now crucial to get these lifesaving tools to the people that need them quickly,” he told a briefing.

The WHO’s approval helps countries worldwide to quickly approve and import a vaccine for distribution, especially those states without an international-standard regulator of their own.

The organisation has also given emergency use listing to vaccines being made by Pfizer-BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the European Union, which it counts separately.

An independent panel of experts said in a statement it recommended Sinovac’s vaccine for adults above 18, with a second dose two to four weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.

NatureNews recalls that on May 7, the WHO granted emergency approval for Sinopharm, the first vaccine produced in China.

below content

Quality journalism costs money. Today, we’re asking that you support us to do more. Support our work by sending in your donations.

The donation can be made directly into NatureNews Account below

Guaranty Trust Bank, Nigeria

0609085876

NatureNews Online

Leave a comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More